Search by Drug Name or NDC
NDC 00169-1913-02 Zegalogue 0.6 mg/.6mL Details
Zegalogue 0.6 mg/.6mL
Zegalogue is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is DASIGLUCAGON.
MedlinePlus Drug Summary
Dasiglucagon injection is used along with emergency medical treatment to treat severe hypoglycemia (very low blood sugar) in adults and children 6 years of age and older with diabetes. Dasiglucagon injection is in a class of medications called glucagon receptor agonists. It works by causing the liver to release stored sugar to the blood.
Related Packages: 00169-1913-02Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Dasiglucagon Injection
Product Information
| NDC | 00169-1913 |
|---|---|
| Product ID | 0169-1913_48d68219-2ba1-426f-a5a0-0cc35e69ff19 |
| Associated GPIs | |
| GCN Sequence Number | 082097 |
| GCN Sequence Number Description | dasiglucagon HCl SYRINGE 0.6 MG/0.6 SUBCUT |
| HIC3 | M4G |
| HIC3 Description | AGENTS TO TREAT HYPOGLYCEMIA (HYPERGLYCEMICS) |
| GCN | 49402 |
| HICL Sequence Number | 047227 |
| HICL Sequence Number Description | DASIGLUCAGON HCL |
| Brand/Generic | Brand |
| Proprietary Name | Zegalogue |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dasiglucagon |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 0.6 |
| Active Ingredient Units | mg/.6mL |
| Substance Name | DASIGLUCAGON |
| Labeler Name | Novo Nordisk |
| Pharmaceutical Class | Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214231 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00169-1913-02 (00169191302)
| NDC Package Code | 0169-1913-02 |
|---|---|
| Billing NDC | 00169191302 |
| Package | 2 PACKAGE in 1 CARTON (0169-1913-02) / 1 CONTAINER in 1 PACKAGE (0169-1913-12) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS |
| Marketing Start Date | 2023-06-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |